Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting

Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting

Recent studies have shown that autologous bone marrow mononuclear cell (aBM-MNC) transplantation can be effectively performed in human beings either by the coronary route or by endoventricular injections. However, scanty data are available for patients undergoing coronary artery bypass grafting (CAB...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American heart journal 2006, Vol.151 (1), p.192-197
Hauptverfasser: Mocini, David, Staibano, Mario, Mele, Luca, Giannantoni, Paride, Menichella, Giacomo, Colivicchi, Furio, Sordini, Paolo, Salera, Paola, Tubaro, Marco, Santini, Massimo
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Bone marrow
Bone Marrow Transplantation
Cardiology
Coronary Artery Bypass
Feasibility Studies
Female
Follow-Up Studies
Heart attacks
Humans
Male
Middle Aged
Myocardial Infarction - surgery
Stem cells
Transplants & implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Recent studies have shown that autologous bone marrow mononuclear cell (aBM-MNC) transplantation can be effectively performed in human beings either by the coronary route or by endoventricular injections. However, scanty data are available for patients undergoing coronary artery bypass grafting (CABG). Accordingly, the aim of this study was to evaluate the feasibility and safety of aBM-MNC transplantation in patients with recent myocardial infarction undergoing CABG. The study population included 36 consecutive patients with recent myocardial infarction (
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2005.02.001